Healthcare Sector Review: Winning and Losing Stocks on Oct 31st

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Adolor Corporation (NASDAQ:ADLR): The shares closed at $4.46, up $2.54, or 132.29%, on the day. Its market capitalization is $207.23 million. About the company: Adolor Corporation is a therapeutic-based biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of pain and the side effects that are caused by current narcotic pain treatments. Adolor’s small molecule product candidates are in clinical trials.
  • Exelixis, Inc. (NASDAQ:EXEL): The shares closed at $7.27, up $1.28, or 21.37%, on the day. Its market capitalization is $937.64 million. About the company: Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
  • Protalix BioTherapeutics (AMEX:PLX): The shares closed at $6.07, up $0.68, or 12.62%, on the day. Its market capitalization is $519.55 million. About the company: Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.
  • Synta Pharmaceuticals (NASDAQ:SNTA): The shares closed at $3.80, up $0.42, or 12.43%, on the day. Its market capitalization is $188.08 million. About the company: Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
  • InterMune, Inc. (NASDAQ:ITMN): The shares closed at $24.58, up $2.32, or 10.42%, on the day. Its market capitalization is $1.49 billion. About the company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease

Losers (% price change)

  • Cubist Pharmaceuticals (NASDAQ:CBST): The shares closed at $38.79, down $1.59, or 3.93%, on the day. Its market capitalization is $2.37 billion. About the company: Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company’s lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.
  • (): The shares closed at $52.45, down $1.94, or 3.56%, on the day. Its market capitalization is $129.40 million.
  • Cornerstone Therapeutics (NASDAQ:CRTX): The shares closed at $6.50, down $0.22, or 3.27%, on the day. Its market capitalization is $168.71 million. About the company: Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body’s inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.
  • Sequenom, Inc. (NASDAQ:SQNM): The shares closed at $4.73, down $0.12, or 2.47%, on the day. Its market capitalization is $469.11 million. About the company: Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom’s products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
  • Pharmasset, Inc. (NASDAQ:VRUS): The shares closed at $71.00, down $1.54, or 2.12%, on the day. Its market capitalization is $5.35 billion. About the company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet